Aloxistatin (E-64d)

Aloxistatin (E-64d) is a peptide-derived amino acid derivative related to the E-64 family, featuring an electrophilic epoxide warhead attached through a glutamate-like side-chain framework that bears an amino acid backbone motif. The molecule contains an amino functional group and a carboxylate/acid functionality consistent with an amino acid-derived scaffold, while the E-64d epoxide provides a strained electrophile for selective covalent interaction with nucleophilic residues in enzyme active sites during biochemical assays. In synthetic and chemical biology workflows, Aloxistatin (E-64d) is employed as a defined small-molecule inhibitor scaffold and as a research tool for studying protease activity and substrate specificity using controlled, structure-defined electrophilic reagents.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP27563

CAS No:88321-09-9

Synonyms/Alias:L-trans-Epoxysuccinyl-Leu-3-methylbutylamide-ethyl ester;Aloxistatin;88321-09-9;Loxistatin;E64d;E64cethylester;EST;EST(pharmaceutical);Aloxistatine[French];Aloxistatinum[Latin];Aloxistatina[Spanish];E-64D;UNII-L5W337AOUR;CHEMBL63440;CCRIS1934;(2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutaneethylester;C17H30N2O5;EP453;NSC694281;BRN5354546;Ethyl(+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate;(2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-2-oxiranecarboxylicacidethylester;ethyl(2S,3S)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate;Oxiranecarboxylicacid,3-((((1S)-3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)-,ethylester,(2S,3S)-;Oxiranecarboxylicacid,3-(((3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)-,ethylester,(2S-(2-alpha,3-beta(R*)))-;SMR000058552

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C17H30N2O5
M.W/Mr.
342.44

Aloxistatin (E-64d) is a stereochemically defined, E-64 family cysteine protease inhibitor derivative that incorporates an amino acid-derived scaffold and an electrophilic warhead designed for irreversible or quasi-irreversible engagement of target thiol enzymes. The molecule contains a protected amino acid motif with a carboxylate/amide-type functionality and a side-chain architecture that supports binding orientation, while the E-64d electrophile can participate in nucleophilic attack by cysteine residues. The presence of a defined double-bond geometry (E configuration) and the chiral amino acid stereocenter(s) enables consistent inhibitor alignment in enzyme active sites, making it a useful biochemical research intermediate and inhibitor standard. The reactivity profile is dominated by the electrophilic center, while remaining functional groups support downstream derivatization strategies used to generate analogs, conjugates, or analytical reference materials.

1. Cysteine Protease Inhibition

Aloxistatin (E-64d) is applied in chemical biology and enzyme mechanistic studies focused on cysteine proteases, where the amino acid-derived binding elements position the electrophilic warhead toward catalytic cysteine. The protected amino acid framework and stereodefined geometry (E-configuration) support reproducible structure-function relationships in inhibitor binding and covalent capture events. The electrophilic functional group can be used to probe active-site reactivity and to compare inhibitor analogs that vary in sterics or electronics while maintaining the amino acid backbone. Aloxistatin (E-64d) thereby serves as a reference inhibitor for mapping protease activity states and for designing next-generation E-64-like covalent probes.

2. Active-Site Labeling Probes

Aloxistatin (E-64d) is utilized in biomolecule labeling workflows that require cysteine-reactive probe chemistry, leveraging the amino acid-derived scaffold to drive selective engagement of thiol-containing enzyme active sites. The molecule's electrophilic center can participate in covalent bond formation with catalytic cysteine residues, while the remaining functional groups can be handled through protection and deprotection logic typical of amino acid derivative synthesis. The stereochemical definition helps maintain predictable binding geometry, which is important when converting the inhibitor into clickable or traceable analogs for proteomic workflows. Aloxistatin (E-64d) can be employed as a chemical handle source for downstream probe construction and active-site occupancy experiments in biochemical research.

3. Peptidomimetic SAR Studies

Aloxistatin (E-64d) is suitable for structure-activity relationship studies and peptidomimetic design efforts that use amino acid-derived inhibitors as scaffold templates. The chiral amino acid stereocenter(s) and the E-geometry contribute to a defined three-dimensional pharmacophore, enabling systematic variation of side-chain substituents, leaving groups, or protective-group patterns while retaining the core covalent warhead motif. The inhibitor's functional groups support synthetic modification routes that generate analog libraries through controlled derivatization of carboxylate/amide regions and side-chain substituents. Aloxistatin (E-64d) thus functions as a reference compound for SAR-driven refinement of covalent cysteine protease inhibitors and related amino acid-based peptidomimetics.

4. Protected Amino Acid Intermediate Use

Aloxistatin (E-64d) is relevant to synthetic organic chemistry and process chemistry as an amino acid-derived derivative that exemplifies protecting-group compatible construction of covalent inhibitors. The presence of amino acid-derived functionality and defined stereochemistry makes the compound a practical benchmark for route design involving N-/C-functional group strategies, including selective deprotection and coupling compatibility considerations. The electrophilic warhead can guide chemoselective planning, where protecting-group stability and orthogonality are evaluated to avoid premature reactivity during intermediate formation. Aloxistatin (E-64d) can therefore be used to support development of protected amino acid synthesis logic and to prepare downstream inhibitor analogs for fine chemical production and research intermediate generation.

5. Analytical Reference Standards

Aloxistatin (E-64d) is applied in analytical research for method development and reference standard preparation in studies of cysteine protease activity and inhibitor engagement. The defined stereochemistry and E-geometry support consistent chromatographic and mass spectrometric behavior, while the amino acid-derived scaffold provides characteristic fragmentation patterns useful for LC-MS/MS identification of inhibitor-related species. The electrophilic center enables monitoring of covalent adduct formation, supporting assay validation and quantitative comparisons across inhibitor analogs. Aloxistatin (E-64d) can be employed as an analytical benchmark for characterizing reaction mixtures, inhibitor stability, and active-site labeling outcomes in biochemical and industrial research settings.

6. Specialty Chemical Production

Aloxistatin (E-64d) is relevant to specialty chemical production and industrial intermediate preparation where amino acid derivative chemistry and controlled electrophile handling are central to manufacturing workflows. The molecule's structured amino acid motif and stereodefined geometry enable reproducible specification of identity and impurity profiles for covalent inhibitor classes. The functional group set supports downstream transformation into related E-64d analogs through targeted functional group modifications, enabling scalable generation of research-grade inhibitor series. Aloxistatin (E-64d) therefore serves as a chemically grounded reference for industrial chemistry planning involving stereochemical fidelity, chemoselective derivatization, and covalent warhead stability considerations.

Size
1 mg;5 mg;
InChI
1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1
InChI Key
SRVFFFJZQVENJC-IHRRRGAJSA-N
Canonical SMILES
CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide Analysis ServicesPeptide Modification ServicesPeptide Nucleic Acids SynthesisPeptide Synthesis ServicescGMP Peptide ServicePeptide CDMOEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers